IBNSINA PHARMA CO |
End-of-day quote
Other stock markets
|
||
| - EGP | - |
|
| 03-03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
| Sales 2024 * | 36.64B 769M 1.05B | Sales 2025 * | 44.09B 925M 1.26B | Capitalization | 2.45B 51.42M 70.25M |
|---|---|---|---|---|---|
| Net income 2024 * | 417M 8.75M 11.96M | Net income 2025 * | 417M 8.75M 11.96M | EV / Sales 2024 * | 0.17 x |
| Net Debt 2024 * | 3.65B 76.59M 105M | Net Debt 2025 * | 3.56B 74.76M 102M | EV / Sales 2025 * | 0.14 x |
| P/E ratio 2024 * |
8.1
x | P/E ratio 2025 * |
6.31
x | Employees | - |
| Yield 2024 * |
1.6% | Yield 2025 * |
3.18% | Free-Float | 61.4% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 00-12-17 | |
| Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Chief Executive Officer | - | 00-12-17 | |
| Chief Executive Officer | - | 00-12-17 |
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Sector
Drug Retailers
| 1st Jan change | Capi. | |
|---|---|---|
| -29.67% | 10.84B | |
| -28.54% | 6.06B | |
| +7.42% | 6.04B | |
| -11.41% | 5.86B | |
| -0.73% | 4.69B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -13.25% | 3.33B | |
| -6.93% | 3.01B |
